Stock DNA
Financial Conglomerates
USD 66 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-999,999.00
-125.37%
18.57
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2023)
Net Profit:
0 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.34%
0%
-4.34%
6 Months
-2.88%
0%
-2.88%
1 Year
1.03%
0%
1.03%
2 Years
7.35%
0%
7.35%
3 Years
6.82%
0%
6.82%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Viveon Health Acquisition Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-155.68%
EBIT to Interest (avg)
-2.75
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
18.57
EV to EBIT
-30.73
EV to EBITDA
-30.73
EV to Capital Employed
8.85
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.79%
ROE (Latest)
-125.37%
Technicals key factors
Indicator
Weekly
Monthly
Technical indicator has not been calculated since the stock has been active for a short period
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 2 Schemes (0.52%)
Foreign Institutions
Held by 11 Foreign Institutions (59.41%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'23 - QoQ
Mar'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.60
-0.10
-500.00%
Interest
0.00
2.50
-100.00%
Exceptional Items
0.50
4.90
-89.80%
Consolidate Net Profit
0.30
2.80
-89.29%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2023 is 0.00% vs 0.00% in Dec 2022
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2023 is -89.29% vs 216.67% in Dec 2022
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.50
-4.10
39.02%
Interest
3.60
0.00
Exceptional Items
4.90
6.60
-25.76%
Consolidate Net Profit
-0.60
2.50
-124.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -124.00% vs 213.64% in Dec 2021
About Viveon Health Acquisition Corp. 
Viveon Health Acquisition Corp.
Financial Conglomerates
No Details Available.
Company Coordinates 
No Company Details Available






